Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
PMEC vs CTAS vs ABM vs KELYA vs MAN
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Business Services
Specialty Business Services
Staffing & Employment Services
Staffing & Employment Services
PMEC vs CTAS vs ABM vs KELYA vs MAN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Specialty Business Services | Specialty Business Services | Staffing & Employment Services | Staffing & Employment Services |
| Market Cap | $28M | $68.52B | $2.39B | $349M | $1.41B |
| Revenue (TTM) | $123M | $10.79B | $8.87B | $3.09B | $17.96B |
| Net Income (TTM) | $-4M | $1.90B | $158M | $-266M | $-13M |
| Gross Margin | 6.5% | 50.2% | 11.5% | 26.3% | 16.7% |
| Operating Margin | -8.8% | 23.0% | 3.7% | -2.8% | 0.8% |
| Forward P/E | — | 34.8x | 10.3x | 11.0x | 8.3x |
| Total Debt | $15M | $2.65B | $1.69B | $159M | $2.39B |
| Cash & Equiv. | $10M | $264M | $104M | $33M | $871M |
PMEC vs CTAS vs ABM vs KELYA vs MAN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 23 | May 26 | Return |
|---|---|---|---|
| Primech Holdings Lt… (PMEC) | 100 | 27.9 | -72.1% |
| Cintas Corporation (CTAS) | 100 | 134.1 | +34.1% |
| ABM Industries Inco… (ABM) | 100 | 103.6 | +3.6% |
| Kelly Services, Inc. (KELYA) | 100 | 54.3 | -45.7% |
| ManpowerGroup Inc. (MAN) | 100 | 43.5 | -56.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PMEC vs CTAS vs ABM vs KELYA vs MAN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, PMEC doesn't own a clear edge in any measured category.
CTAS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 7.7%, EPS growth 16.1%, 3Y rev CAGR 9.6%
- 6.9% 10Y total return vs ABM's 48.7%
- Lower volatility, beta 0.51, Low D/E 56.7%, current ratio 2.09x
- Beta 0.51, yield 0.9%, current ratio 2.09x
ABM is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 36 yrs, beta 0.72, yield 2.6%
- PEG 0.04 vs CTAS's 2.08
- Lower P/E (10.3x vs 34.8x), PEG 0.04 vs 2.08
KELYA ranks third and is worth considering specifically for momentum.
- -12.2% vs PMEC's -41.1%
MAN is the clearest fit if your priority is dividends.
- 4.7% yield, vs ABM's 2.6%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.7% revenue growth vs KELYA's -1.9% | |
| Value | Lower P/E (10.3x vs 34.8x), PEG 0.04 vs 2.08 | |
| Quality / Margins | 17.6% margin vs KELYA's -8.6% | |
| Stability / Safety | Beta 0.51 vs MAN's 1.03, lower leverage | |
| Dividends | 4.7% yield, vs ABM's 2.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | -12.2% vs PMEC's -41.1% | |
| Efficiency (ROA) | 18.7% ROA vs KELYA's -11.3%, ROIC 25.8% vs -4.0% |
PMEC vs CTAS vs ABM vs KELYA vs MAN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PMEC vs CTAS vs ABM vs KELYA vs MAN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CTAS leads in 3 of 6 categories
MAN leads 1 • PMEC leads 0 • ABM leads 0 • KELYA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CTAS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MAN is the larger business by revenue, generating $18.0B annually — 145.4x PMEC's $123M. CTAS is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to KELYA's -8.6%. On growth, PMEC holds the edge at +28.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $123M | $10.8B | $8.9B | $3.1B | $18.0B |
| EBITDAEarnings before interest/tax | -$4M | $2.9B | $431M | -$54M | $236M |
| Net IncomeAfter-tax profit | -$4M | $1.9B | $158M | -$266M | -$13M |
| Free Cash FlowCash after capex | -$3M | $1.8B | $327M | $66M | -$161M |
| Gross MarginGross profit ÷ Revenue | +6.5% | +50.2% | +11.5% | +26.3% | +16.7% |
| Operating MarginEBIT ÷ Revenue | -8.8% | +23.0% | +3.7% | -2.8% | +0.8% |
| Net MarginNet income ÷ Revenue | -3.1% | +17.6% | +1.8% | -8.6% | -0.1% |
| FCF MarginFCF ÷ Revenue | -2.2% | +16.5% | +3.7% | +2.1% | -0.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +28.8% | +9.3% | +6.1% | -100.0% | +7.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +57.5% | +11.0% | -7.2% | -2.1% | +36.2% |
Valuation Metrics
MAN leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 15.7x trailing earnings, ABM trades at a 59% valuation discount to CTAS's 38.6x P/E. Adjusting for growth (PEG ratio), ABM offers better value at 0.05x vs CTAS's 2.31x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $28M | $68.5B | $2.4B | $349M | $1.4B |
| Enterprise ValueMkt cap + debt − cash | $34M | $70.9B | $4.0B | $475M | $2.9B |
| Trailing P/EPrice ÷ TTM EPS | -14.02x | 38.65x | 15.74x | -1.34x | -104.90x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 34.75x | 10.30x | 10.96x | 8.28x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.31x | 0.05x | — | — |
| EV / EBITDAEnterprise value multiple | 10.19x | 24.85x | 9.23x | — | 9.02x |
| Price / SalesMarket cap ÷ Revenue | 0.38x | 6.63x | 0.27x | 0.08x | 0.08x |
| Price / BookPrice ÷ Book value/share | 1.85x | 14.89x | 1.43x | 0.35x | 0.69x |
| Price / FCFMarket cap ÷ FCF | 4.50x | 39.00x | 15.40x | 3.06x | — |
Profitability & Efficiency
CTAS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CTAS delivers a 42.6% return on equity — every $100 of shareholder capital generates $43 in annual profit, vs $-43 for PMEC. KELYA carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to MAN's 1.16x. On the Piotroski fundamental quality scale (0–9), CTAS scores 9/9 vs MAN's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -42.7% | +42.6% | +8.8% | -24.6% | -0.6% |
| ROA (TTM)Return on assets | -8.8% | +18.7% | +3.0% | -11.3% | -0.1% |
| ROICReturn on invested capital | -2.1% | +25.8% | +7.5% | -4.0% | +5.6% |
| ROCEReturn on capital employed | -3.2% | +29.8% | +8.2% | -4.3% | +6.2% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 9 | 6 | 5 | 1 |
| Debt / EquityFinancial leverage | 1.05x | 0.57x | 0.95x | 0.16x | 1.16x |
| Net DebtTotal debt minus cash | $5M | $2.4B | $1.6B | $126M | $1.5B |
| Cash & Equiv.Liquid assets | $10M | $264M | $104M | $33M | $871M |
| Total DebtShort + long-term debt | $15M | $2.7B | $1.7B | $159M | $2.4B |
| Interest CoverageEBIT ÷ Interest expense | -2.35x | 24.61x | 3.25x | -12.07x | 1.98x |
Total Returns (Dividends Reinvested)
CTAS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTAS five years ago would be worth $19,584 today (with dividends reinvested), compared to $3,514 for MAN. Over the past 12 months, KELYA leads with a -12.2% total return vs PMEC's -41.1%. The 3-year compound annual growth rate (CAGR) favors CTAS at 14.9% vs PMEC's -20.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -32.5% | -7.8% | -3.1% | +13.1% | +1.2% |
| 1-Year ReturnPast 12 months | -41.1% | -20.1% | -16.0% | -12.2% | -17.0% |
| 3-Year ReturnCumulative with dividends | -50.3% | +51.7% | +3.4% | -34.2% | -46.4% |
| 5-Year ReturnCumulative with dividends | -50.3% | +95.8% | -14.1% | -58.3% | -64.9% |
| 10-Year ReturnCumulative with dividends | -50.3% | +685.0% | +48.7% | -33.0% | -30.8% |
| CAGR (3Y)Annualised 3-year return | -20.8% | +14.9% | +1.1% | -13.0% | -18.8% |
Risk & Volatility
Evenly matched — CTAS and ABM each lead in 1 of 2 comparable metrics.
Risk & Volatility
CTAS is the less volatile stock with a 0.51 beta — it tends to amplify market swings less than MAN's 1.03 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ABM currently trades 77.0% from its 52-week high vs PMEC's 30.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.94x | 0.51x | 0.72x | 1.01x | 1.03x |
| 52-Week HighHighest price in past year | $2.44 | $229.24 | $52.94 | $14.94 | $47.34 |
| 52-Week LowLowest price in past year | $0.52 | $165.46 | $36.96 | $7.98 | $25.15 |
| % of 52W HighCurrent price vs 52-week peak | +30.2% | +74.2% | +77.0% | +64.9% | +64.3% |
| RSI (14)Momentum oscillator 0–100 | 47.7 | 37.7 | 54.8 | 63.7 | 47.1 |
| Avg Volume (50D)Average daily shares traded | 681K | 2.2M | 512K | 361K | 1.1M |
Analyst Outlook
Evenly matched — ABM and MAN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CTAS as "Hold", ABM as "Hold", KELYA as "Buy", MAN as "Hold". Consensus price targets imply 54.6% upside for KELYA (target: $15) vs 22.7% for ABM (target: $50). For income investors, MAN offers the higher dividend yield at 4.71% vs CTAS's 0.88%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | $223.40 | $50.00 | $15.00 | $37.86 |
| # AnalystsCovering analysts | — | 30 | 11 | 5 | 29 |
| Dividend YieldAnnual dividend ÷ price | — | +0.9% | +2.6% | +3.2% | +4.7% |
| Dividend StreakConsecutive years of raises | 0 | 3 | 36 | 5 | 0 |
| Dividend / ShareAnnual DPS | — | $1.49 | $1.05 | $0.31 | $1.43 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.4% | +5.1% | +3.5% | +2.7% |
CTAS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MAN leads in 1 (Valuation Metrics). 2 tied.
PMEC vs CTAS vs ABM vs KELYA vs MAN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PMEC or CTAS or ABM or KELYA or MAN a better buy right now?
For growth investors, Cintas Corporation (CTAS) is the stronger pick with 7.
7% revenue growth year-over-year, versus -1. 9% for Kelly Services, Inc. (KELYA). ABM Industries Incorporated (ABM) offers the better valuation at 15. 7x trailing P/E (10. 3x forward), making it the more compelling value choice. Analysts rate Kelly Services, Inc. (KELYA) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PMEC or CTAS or ABM or KELYA or MAN?
On trailing P/E, ABM Industries Incorporated (ABM) is the cheapest at 15.
7x versus Cintas Corporation at 38. 6x. On forward P/E, ManpowerGroup Inc. is actually cheaper at 8. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ABM Industries Incorporated wins at 0. 04x versus Cintas Corporation's 2. 08x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PMEC or CTAS or ABM or KELYA or MAN?
Over the past 5 years, Cintas Corporation (CTAS) delivered a total return of +95.
8%, compared to -64. 9% for ManpowerGroup Inc. (MAN). Over 10 years, the gap is even starker: CTAS returned +685. 0% versus PMEC's -50. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PMEC or CTAS or ABM or KELYA or MAN?
By beta (market sensitivity over 5 years), Cintas Corporation (CTAS) is the lower-risk stock at 0.
51β versus ManpowerGroup Inc. 's 1. 03β — meaning MAN is approximately 103% more volatile than CTAS relative to the S&P 500. On balance sheet safety, Kelly Services, Inc. (KELYA) carries a lower debt/equity ratio of 16% versus 116% for ManpowerGroup Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PMEC or CTAS or ABM or KELYA or MAN?
By revenue growth (latest reported year), Cintas Corporation (CTAS) is pulling ahead at 7.
7% versus -1. 9% for Kelly Services, Inc. (KELYA). On earnings-per-share growth, the picture is similar: ABM Industries Incorporated grew EPS 102. 3% year-over-year, compared to -427. 4% for Kelly Services, Inc.. Over a 3-year CAGR, PMEC leads at 10. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PMEC or CTAS or ABM or KELYA or MAN?
Cintas Corporation (CTAS) is the more profitable company, earning 17.
5% net margin versus -6. 0% for Kelly Services, Inc. — meaning it keeps 17. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTAS leads at 22. 8% versus -1. 6% for KELYA. At the gross margin level — before operating expenses — CTAS leads at 50. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PMEC or CTAS or ABM or KELYA or MAN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ABM Industries Incorporated (ABM) is the more undervalued stock at a PEG of 0. 04x versus Cintas Corporation's 2. 08x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ManpowerGroup Inc. (MAN) trades at 8. 3x forward P/E versus 34. 8x for Cintas Corporation — 26. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KELYA: 54. 6% to $15. 00.
08Which pays a better dividend — PMEC or CTAS or ABM or KELYA or MAN?
In this comparison, MAN (4.
7% yield), KELYA (3. 2% yield), ABM (2. 6% yield), CTAS (0. 9% yield) pay a dividend. PMEC does not pay a meaningful dividend and should not be held primarily for income.
09Is PMEC or CTAS or ABM or KELYA or MAN better for a retirement portfolio?
For long-horizon retirement investors, Cintas Corporation (CTAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
51), 0. 9% yield, +685. 0% 10Y return). Both have compounded well over 10 years (CTAS: +685. 0%, PMEC: -50. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PMEC and CTAS and ABM and KELYA and MAN?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PMEC is a small-cap quality compounder stock; CTAS is a mid-cap quality compounder stock; ABM is a small-cap deep-value stock; KELYA is a small-cap income-oriented stock; MAN is a small-cap income-oriented stock. CTAS, ABM, KELYA, MAN pay a dividend while PMEC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.